Dynavax Technologies Corp (NASDAQ:DVAX)

19.72
Delayed Data
As of Mar 03
 +0.91 / +4.84%
Today’s Change
12.50
Today|||52-Week Range
20.90
+16.96%
Year-to-Date

Today’s Trading

Previous close18.81
Today’s open18.90
Day’s range-- - --
Volume709,070
Average volume (3 months)335,343
Market cap$494.6M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)-0.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.33+2.56%
PGNXProgenics Pharmaceut...+0.13+1.95%
EGRXEagle Pharmaceutical...-0.99-2.63%
VTLVital Therapies Inc+0.14+0.63%
Data as of 03/03/2015

Financials

Last reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account